CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,761,855 | +18.3% | 248,187 | -3.4% | 0.00% | 0.0% |
| Q2 2023 | $5,715,870 | -5.5% | 256,893 | -8.0% | 0.00% | 0.0% |
| Q1 2023 | $6,050,958 | +6.3% | 279,361 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $5,691,128 | -19.1% | 280,213 | +2.1% | 0.00% | -33.3% |
| Q3 2022 | $7,035,000 | +7.3% | 274,414 | -0.5% | 0.00% | +50.0% |
| Q2 2022 | $6,559,000 | +4.7% | 275,802 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $6,264,000 | +13.4% | 278,143 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $5,525,000 | -3.3% | 279,012 | -3.9% | 0.00% | 0.0% |
| Q3 2021 | $5,711,000 | -3.5% | 290,211 | +7.8% | 0.00% | 0.0% |
| Q2 2021 | $5,921,000 | -27.0% | 269,104 | -21.1% | 0.00% | -33.3% |
| Q1 2021 | $8,116,000 | -6.3% | 341,119 | +3.1% | 0.00% | 0.0% |
| Q4 2020 | $8,658,000 | +53.5% | 330,983 | +2.1% | 0.00% | 0.0% |
| Q3 2020 | $5,641,000 | +5.4% | 324,127 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $5,353,000 | +51.9% | 318,233 | +7.4% | 0.00% | +50.0% |
| Q1 2020 | $3,525,000 | -1.4% | 296,437 | +0.3% | 0.00% | 0.0% |
| Q4 2019 | $3,575,000 | -8.3% | 295,483 | +7.1% | 0.00% | 0.0% |
| Q3 2019 | $3,899,000 | +32.6% | 275,820 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $2,940,000 | -4.9% | 263,673 | +0.1% | 0.00% | 0.0% |
| Q1 2019 | $3,093,000 | -3.2% | 263,475 | +9.3% | 0.00% | 0.0% |
| Q4 2018 | $3,194,000 | -5.8% | 241,044 | -1.0% | 0.00% | 0.0% |
| Q3 2018 | $3,390,000 | +3.3% | 243,395 | +16.8% | 0.00% | -33.3% |
| Q2 2018 | $3,281,000 | +3.3% | 208,388 | +6.7% | 0.00% | +50.0% |
| Q1 2018 | $3,177,000 | +1.8% | 195,352 | +13.0% | 0.00% | 0.0% |
| Q4 2017 | $3,121,000 | +581.4% | 172,821 | +623.4% | 0.00% | – |
| Q3 2017 | $458,000 | +65.9% | 23,890 | +2.7% | 0.00% | – |
| Q2 2017 | $276,000 | +40.8% | 23,261 | +31.9% | 0.00% | – |
| Q1 2017 | $196,000 | +49.6% | 17,638 | -1.5% | 0.00% | – |
| Q4 2016 | $131,000 | +107.9% | 17,914 | +80.9% | 0.00% | – |
| Q3 2016 | $63,000 | +16.7% | 9,902 | 0.0% | 0.00% | – |
| Q2 2016 | $54,000 | – | 9,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |